ARCHIVES

New NCAB Weak In Grant Reviews, Confused By Issues

This article is from The Cancer Letter archive.

Vol. 08 No. 48 | December 10, 1982

Download PDF Visit The Full Archive

Related Articles

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

DeVita Considers Laetrile Tests

June 3, 1977

NIH director would have broad authority over institute budgets in proposed bill.

July 22, 2005

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

Professional Societies: AACI Seeks To Define Role Of Cancer Centers In Washington Politics

October 16, 1998

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009